Fidelity Investments
LKFT

Fidelity Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Fidelity Investments’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30 Sell
1
-56,968
-100% -$1.89M ﹤0.01% 5326
2025
Q4 		$1.86M Buy
56,969
+2,958
+5% +$95.5K ﹤0.01% 2646
2025
Q3 		$1.87M Sell
54,011
-1,493,017
-97% -$47.8M ﹤0.01% 2566
2025
Q2 		$43.3M Sell
1,547,028
-9,828
-0.6% -$263K ﹤0.01% 1448
2025
Q1 		$39.1M Sell
1,556,856
-37,953
-2% -$959K ﹤0.01% 1443
2024
Q4 		$43.9M Sell
1,594,809
-4,103
-0.3% -$114K ﹤0.01% 1431
2024
Q3 		$46M Sell
1,598,912
-1,288,919
-45% -$35.1M ﹤0.01% 1417
2024
Q2 		$71.6M Sell
2,887,831
-1,286,686
-31% -$36.5M ﹤0.01% 1173
2024
Q1 		$134M Sell
4,174,517
-59,286
-1% -$2.2M 0.01% 942
2023
Q4 		$172M Sell
4,233,803
-83,873
-2% -$3.09M 0.01% 800
2023
Q3 		$149M Buy
4,317,676
+28,497
+0.7% +$1.11M 0.01% 813
2023
Q2 		$174M Buy
4,289,179
+342,646
+9% +$14M 0.01% 768
2023
Q1 		$152M Buy
3,946,533
+50,156
+1% +$2.06M 0.01% 826
2022
Q4 		$173M Buy
3,896,377
+176,789
+5% +$7.44M 0.02% 744
2022
Q3 		$159M Buy
3,719,588
+150,938
+4% +$7.73M 0.02% 761
2022
Q2 		$199M Buy
3,568,650
+1,401,691
+65% +$83.1M 0.02% 686
2022
Q1 		$134M Buy
2,166,959
+2,117,458
+4,278% +$130M 0.01% 945
2021
Q4 		$2.73M Sell
49,501
-37,739
-43% -$1.97M ﹤0.01% 2495
2021
Q3 		$4.59M Sell
87,240
-517,259
-86% -$30.7M ﹤0.01% 2391
2021
Q2 		$41.6M Sell
604,499
-24
-0% -$1.83K ﹤0.01% 1534
2021
Q1 		$46.6M Sell
604,523
-80,695
-12% -$7.43M ﹤0.01% 1439
2020
Q4 		$67.8M Sell
685,218
-268,622
-28% -$32.8M 0.01% 1200
2020
Q3 		$135M Sell
953,840
-71,855
-7% -$12M 0.01% 791
2020
Q2 		$202M Sell
1,025,695
-292,726
-22% -$60.6M 0.02% 608
2020
Q1 		$258M Buy
1,318,421
+716,469
+119% +$154M 0.04% 421
2019
Q4 		$125M Sell
601,952
-58,449
-9% -$10.8M 0.01% 833
2019
Q3 		$101M Sell
660,401
-106,214
-14% -$17.4M 0.01% 888
2019
Q2 		$98.8M Buy
766,615
+264,422
+53% +$31.4M 0.01% 921
2019
Q1 		$59.1M Buy
502,193
+131,119
+35% +$13.2M 0.01% 1144
2018
Q4 		$34M Sell
371,074
-360,208
-49% -$36.5M ﹤0.01% 1328
2018
Q3 		$82.2M Sell
731,282
-71,096
-9% -$7.51M 0.01% 1034
2018
Q2 		$74M Sell
802,378
-1,038,208
-56% -$101M 0.01% 1088
2018
Q1 		$184M Sell
1,840,586
-670,406
-27% -$72.3M 0.02% 725
2017
Q4 		$235M Sell
2,510,992
-291,339
-10% -$27.6M 0.03% 627
2017
Q3 		$285M Sell
2,802,331
-756,589
-21% -$66.1M 0.03% 539
2017
Q2 		$272M Sell
3,558,920
-1,066,687
-23% -$89.7M 0.03% 552
2017
Q1 		$399M Hold
4,625,607
– – 0.05% 402
2016
Q4 		$297M Buy
4,625,607
+8,625
+0.2% +$531K 0.04% 496
2016
Q3 		$299M Buy
4,616,982
+6,032
+0.1% +$340K 0.04% 492
2016
Q2 		$256M Buy
4,610,950
+27,246
+0.6% +$1.37M 0.03% 558
2016
Q1 		$192M Buy
4,583,704
+676,070
+17% +$31.4M 0.03% 670
2015
Q4 		$246M Buy
3,907,634
+11,350
+0.3% +$580K 0.03% 572
2015
Q3 		$159M Buy
3,896,284
+6,826
+0.2% +$393K 0.02% 747
2015
Q2 		$200M Buy
+3,889,458
New +$206M 0.03% 691

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments's LKFT Position: Q1 2026 in Review

Fidelity Investments reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 100% in Q1 2026, selling an estimated $1.89M and leaving 1 share worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #5326.

Fidelity Investments first reported a position in LKFT in Q2 2015 and has held it in 44 quarters since. The position peaked at $399M in Q1 2017. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Fidelity Investments held 1 share of Lakefront Biotherapeutics American Depositary Shares worth $30 as of Q1 2026.
  • Fidelity Investments sold 56,968 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $1.89M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5326 holding.
  • Fidelity Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 44 quarters since.
  • Fidelity Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $399M in Q1 2017.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.